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The bee venom neurotoxin apamin has been labelled with “‘1 and its binding to isolated guinea-pig 
hepatocytes measured under physiological conditions. A single saturable component of 
[‘251]monoiodoapamin binding with a & of 350 pM and B max of 0.99 fmol/mg dry wt was identified. 
Native apamin displaced labelled apamin with a Kd of 376 pM which is broadly in keeping with the 
concentrations found to inhibit K loss from guinea-pig hepatocytes. These observations, together with the 
binding found in other tissues, suggest hat specific binding of labelled apamin is particularly associated 
with apamin-sensitive, Ca-activated K-channels. 
Apamin Guinea-pig hepatocyte Ca-activated K-channel 
1. INTRODUCTION 
Ca’+-dependent K+-conductance channels are a 
feature of the plasma membrane of many types of 
cell (e.g., erythrocytes, certain neurones, intestinal 
smooth muscle and hepatocytes of some species). 
Elevation of the intracellular [Ca2’] leads to an in- 
crease in potassium permeability which normally 
results in the loss of cell potassium and hyper- 
polarization of the cell membrane [l]. Apamin, a 
neurotoxic polypeptide isolated from bee venom, 
has recently been shown to block this K- 
conductance increase in guinea-pig hepatocytes 
[l], smooth muscle [2,3,4] and neuroblastoma cells 
[5]. Apamin can be labelled with 12’I; the 
monoiodinated derivative is biologically active and 
binds with high affinity to a variety of tissue 
homogenates [5,6], membranes [7] and synap- 
tosomes [a]. 
binding site has been obtained from competition 
studies and related to its activity in blocking the ef- 
flux of potassium from liver cells under essentially 
identical conditions. 
2. MATERIALS AND METHODS 
2.1. Isolation of guinea-pig hepatocytes 
Hepatocytes were prepared from male Hartley 
guinea pigs as described in [l]. Viability assessed 
by Trypan blue exclusion was typically 80-90%; 
potassium content of the cells was 275.1 f 
4.5 mmol/kg dry wt (+ SE, n = 56). Cells were in- 
cubated and experiments conducted at 37°C in 
Eagle’s MEM (Wellcome) supplemented with 2% 
bovine serum albumin and 10% newborn calf 
serum. Cell suspensions contained about 8 x lo6 
cells/ml (lo6 cells = 2.5 mg dry wt). 
This communication describes, for the first 
time, the binding of [‘251]monoiodoapamin to in- 
tact cells under physiological conditions. An 
estimate of the affinity of native apamin for its 
2.2. Preparation of [‘251Jmonoiodoapamin 
* To whom correspondence should be addressed 
Apamin was radioiodinated and purified essen- 
tially as in [a]. The reaction mixture (monoiodo-, 
diiodo- and a large excess of unlabelled apamin) 
was separated using an SP Sephadex C25 column 
(12 x 0.9 cm), equilibrated with 160 mM NaCI, 
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50 mM sodium phosphate buffer, pH 6.0. The col- 
umn was eluted with the equilibration buffer, in- 
creasing the NaCl concentration stepwise to 
300 mM after 20 ml. The later fractions of the 
monoiodoapamin peak were discarded to avoid 
contamination by native apamin [8]. Thin-layer 
chromatography (TLC) of the monoiodoapamin 
peak revealed a single radioactive spot whose Rf- 
value corresponded to that expected for 
monoiodoapamin [6]. The purity of the 
[12’I]monoiodoapamin was checked by TLC at 
regular intervals. Assuming 100% isotopic abun- 
dance, the spec. act. of the [‘251]monoiodoapamin 
is 2000 Ci/mmol and the concentration of the 
labelled compound in the fractions could accor- 
dingly be determined by measuring radioactivity in 
a calibrated y counter. It was impractical to desalt 
the monoiodoapamin fractions from the ion ex- 
change column. Consequently, concentrations of 
[1251]monoiodoapamin greater than 600 pM were 
avoided in order to prevent large changes in 
sodium chloride concentration and pH, originating 
from the elution buffer. 
2.3. Binding studies 
In the experiments described below 
[1251]monoiodoapamin which had become 
associated with cells was separated from free- 
labelled apamin by rapid centrifugation of the cells 
through di-n-butylphthalate (BDH, referred to 
subsequently as ‘oil’) [9]. Some extracellular fluid 
was carried through with the cells and studies with 
[3H]inulin suggested that most of the ‘non- 
inhibitable’ binding of labelled apamin was at- 
tributable to this phenomenon. The terms ‘in- 
hibitable’ and ‘non-inhibitable’ are used in 
preference to the more common ‘specific’ and 
‘non-specific’ because the former do not assume a 
particular pharmacological significance of the 
binding. 
2.3.1. Kinetic studies 
6 ml of incubation medium containing labelled 
apamin was added to 9 ml of cell suspension in a 
conical flask (final [‘251]monoiodoapamin concen- 
tration 16 PM). The cells were shaken at 37°C 
under a gas phase of 5% CO2 in 02. At fixed time 
intervals two 0.5ml aliquots were removed, added 
to 1.5 ml Eppendorf tubes containing 0.25 ml of 
oil and immediately centrifuged for 15 s at 6000 x 
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g. The aqueous and oil layers were removed and 
the bottom of the tube, containing the cell pellet, 
cut off and counted. The rate of association of 
labelled apamin with the cells was studied in this 
way over a period of 9.5 min. Dissociation of 
tracer was monitored in a second flask to which 
1 FM apamin was added after 3.5 min. In a third 
flask 1 PM apamin was present throughout to 
follow non-inhibitable binding. 
2.3.2. Equilibrium binding 
0.2 ml of incubation medium containing a range 
of concentrations of labelled apamin was added to 
quadruplicate Eppendorf tubes containing 0.3 ml 
of cell suspension layered above 0.25 ml of oil. 
After 2 min at 37°C the tubes were centrifuged and 
the pellets counted as described above. Non- 
inhibitable binding was determined in a parallel set 
of tubes containing 1 ,uM unlabelled apamin. Free 
[rZ51]monoiodoapamin concentrations have not 
been corrected for the small reduction due to bin- 
ding (always less than 3%). 
2.3.3. Competition experiments 
0.3 ml of cell suspension was incubated with 
0.2 ml of incubation medium containing labelled 
apamin (final concentration 46 PM) and varying 
concentrations of unlabelled apamin (final concen- 
trations 10 pM-1 PM). After 2 min the bound 
labelled apamin was measured as described above. 
2.4. Potassium loss experiments 
Potassium release from hepatocytes in response 
to a-adrenoceptor activation was determined using 
a K-sensitive electrode immersed in a suspension of 
the cells [l]. Potassium loss in the first 30 s after 
drug application was expressed as a percentage of 
the total cell K content, evaluated for each aliquot 
of cells by the subsequent addition of 100pM 
digitonin, which caused complete release of 
potassium from the cells. Apamin was applied 
3 min before phenylephrine. All solutions contain- 
ed 5 FM ( + )-propranolol to prevent any P-actions 
of phenylephrine. 
3. RESULTS 
3.1. Kinetics of [1251]monoiodoapamin b ding 
Fig.1 shows that at 37°C in physiological solu- 
tion the uptake of labelled apamin from a 16 pM 
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Fig. 1. Binding of [~zsIJmonoiodoapamin as a function 
of time. Guinea-pig hepatocytes were exposed to 16 pM 
labelled apamin at f = 0. Filled circles and filled squares 
show the time course of total and non-inhibitable 
binding respectively. Open circles show the reduction in 
total binding, due to dissociation of labelled apamin 
from saturable sites, following the addition of 1 ,uM 
apamin at 3.5 min. Points are means +- SE from 3 expts, 
each performed in duplicate. 
solution is largely complete in 2 min, the half-time 
being about 20 s. Dissociation, initiated by adding 
an excess of native apamin, had a similar time 
course. These observations validate the use of a 
2 min incubation in the experiments described in 
2.3.2 and 2.3.3 and stress the importance of a 
rapid technique for isolating bound from free 
ligand. 
3.2. Equilibrium binding of f’2sIJmonoiodo- 
apamin to guinea-pig hepatocytes 
Fig.2 shows the combined results of 5 ex- 
periments. ‘con-inhibitable’ binding increased 
linearly with the concentration of labelled apamin 
over the range 5-600 pM. When this component 
was subtracted from the values for ‘total’ binding 
a saturable ‘inhibitable’ component was iden- 
tifiable. A non-linear least squares computer fit 
[lo] of the data was performed for total binding 
according to equation (1): 
u-1 
B = &ax 
KL + IL1 
+ mfL1 
where: 
Fig.2 Binding of [‘zsI]monoiodoapamin to guinea-pig 
hepatocytes as a function of concentration. Points are 
means + SE from 5 expts (4-8 observations/expt). The 
curve for total binding (T) is a least squares fit of a linear 
plus a hyperbolic saturable component (see text). NI 
indicates non-inhibitable binding. The theoretical 
saturable (inhibitable) component alone is represented 
by curve I. 
B = the amount of labelled apamin bound; 
3 max = the total binding capacity of the inhibit- 
able component; 
[Ll = the concentration of labelled apamin; 
KL = its equilibrium dissociation constant. 
The coefficient for non-inhibitable binding, m, 
was constrained to be the slope of the fitted linear 
regression line (1.36 ,ul/mg dry wt) obtained direct- 
ly from the data for non-inhibitable binding. With 
the data weighted inversely with variance, the 
values giving the best fit were: KL = 350 pM and 
B max = 0.99 fmol/mg dry wt. Since concentrations 
above 600 pM could not be used (see section 2) 
these estimates are relatively imprecise (approx- 
imate SD’s based on the variance of residuals being 
60 pM and 0.15 fmob’mg dry wt, respectively). 
3.3. Competition between apamin and f’““IJ- 
monoiodoapamin 
The results of 3 experiments in which the bin- 
ding of 46 pM labelled apamin was inhibited by 
native apamin are shown in fig.3. The inhibition 
observed is consistent with simple competition at a 
single class of binding site and the data has accor- 
dingly been subjected to a non-linear least squares 
fit to equation (2): 
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Fig.3. Inhibition of [‘251]monoiodoapamin binding to 
guinea-pig hepatocytes by native apamin. The 
concentration of labelled apamin was 46 pM. The curve 
is drawn according to equation (2) using the least squares 
estimates for KU, Bo and B, (see text). Points are 
means f SE from 3 expts (5 observations/expt). 
1 + [L]/KL 
B = B, + (B,,-B,) ~~ -~~ 
1 + [L]/KL + [U/K” 
(2) 
where: 
B = 
BO and B, = 
WI = 
KL and KU = 
the amount of labelled apamin 
bound in the presence of unlabelled 
apamin at concentration [q; 
the amounts bound in the absence, 
or in the presence of an excess, of 
unlabelled apamin, respectively; 
the fixed concentration of labelled 
apamin (46 PM); 
the equilibrium dissociation con- 
stants for labelled and unlabelled 
apamin, respectively. 
KL was given the value 350 pM (from the results 
of fig.2). With points weighted inversely with their 
variance, the fitted value for KU was 376 pM (ap- 
proximate SD = 83 PM). 
3.4. Inhibition of potassium loss from hepatocytes 
by apamin 
As has previously been demonstrated [ 1,111, a- 
adrenoceptor agonists cause a loss of potassium 
from guinea-pig liver cells. Increasing concentra- 
tions of apamin produced a progressive depression 
of the dose-response curve to phenylephrine 
(fig.4), the fractional block being relatively in- 
dependent of the agonist concentration; 50% in- 
hibition of the initial rate of potassium loss was 
obtained with about 1 nM apamin. 
0’ 
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Fig.4. Inhibition of K release from guinea-pig 
hepatocytes in response to (-)-phenylephrine by 
apamin. Potassium loss is expressed as the % of cell K 
lost during the first 30 s of exposure to phenylephrine. 
Apamin was added 3 min before phenylephrine at the 
concentrations shown on the right. Means of 4-9 
observations k SE. 
3.5. Binding of [‘2’I]monoiodoapamin to human 
erythrocytes and rat hepatocytes 
The binding of labelled apamin to erythrocytes 
and rat hepatocytes was investigated under iden- 
tical conditions to those described for guinea-pig 
hepatocytes. Human red blood cells showed no 
significant inhibitable binding at concentrations up 
to 500 pM. Similarly in 4 experiments with rat 
hepatocytes significant inhibitable binding could 
not be detected at concentrations of 9, 115 and 
500 pM; e.g., with 115 pM labelled apamin in- 
hibitable binding was 0.0067 + 0.0041 (SE) 
fmol/mg dry wt, representing only 5% of the total 
binding, which compares with 0.245 + 
0.014 fmol/mg dry wt inhibitable binding to 
guinea-pig hepatocytes (61% of total) at the same 
concentration. 
4. DISCUSSION 
The present results demonstrate a saturable 
component of [1251]monoiodoapamin binding to 
guinea-pig hepatocytes. The rapid attainment of 
equilibrium and rapid dissociation (fig. 1) suggests 
that binding primarily occurs at the level of the cell 
membrane and that there is negligible intracellular 
uptake of the toxin. The lack of inhibitable bin- 
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ding in rat liver cells also argues against the 
presence of an active uptake mechanism. The 
estimated & for inhibitable binding, 350 pM, lies 
between the values reported for preparations from 
neuroblastoma cells, 71 pM [S], and guinea-pig 
colon, 700 pM [7] (binding studies in physiological 
medium but at OOC). Much lower values are 
reported for binding studies in solutions of low 
ionic strength [5,7,8]. Our competition ex- 
periments showed native apamin to have a similar 
affinity (& = 376 PM) to the iodinated derivative. 
The density of binding sites was estimated to be 
0.99 fmol/mg dry wt of cells, corresponding to 
about 1500 sites/cell. 
Concern has been expressed over the stability of 
[‘251]monoiodoapamin at 37°C [6,7]. However, as 
fig.1 shows, binding is well maintained after 
10 min incubation at this temperature, suggesting 
that degradation is not a problem with relatively 
short incubations. 
The results with other tissues suggest hat the in- 
hibitable binding is directly related to the presence 
of apamin-sensitive K-channels. Firstly, we were 
unable to demonstrate significant inhibitable bin- 
ding to rat hepatocytes, which do not appear to 
possess Ca-activated K-channels. However, a re- 
cent report 1121 describes exceptionally high affini- 
ty binding (& = 0.135 PM) of 3H-labelled apamin 
to rat liver plasma membranes, suggesting there 
may be a binding component either too small to be 
detected or absent in whole cells under the present 
experimental conditions, Secondly, intestinal 
smooth muscle, in which a-mediated relaxation is 
inhibited by apamin [2], also binds 
monoiodoapamin with high affinity ([7], and our 
own unpublished observations). Finally, red blood 
cells are particularly interesting in that their Ca- 
dependent K-conductance is not blocked by 
apamin 111, and in keeping with this observation 
we also have failed to detect any inhibitable bin- 
ding of labelled apamin to these cells. 
The relatively simple and indirect measure of in- 
hibition of K-conductance provided by the present 
experiments (see fig.4) suggests that, after 3 min, 
1 nM apamin has probably inactivated at least 
5OVo of the K-channels. A Kd of 376 pM, as sug- 
gested by the competition studies, would result in 
73% of the sites being occupied at this concentra- 
tion. Thus, if we assume that binding site occupan- 
cy corresponds to channel block, it appears that 
the measured & is consistent with the degree of 
block that we observe. 
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